MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 27, 2007; DOI: 10.1124/mol.107.039370


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.039370v1
72/5/1380    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tan, K. P.
Right arrow Articles by Ito, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tan, K. P.
Right arrow Articles by Ito, S.


Received for publication June 27, 2007.
Revised August 9, 2007.
Accepted for publication August 27, 2007.

Activation of Nrf2 by Toxic Bile Acids Provokes Adaptive Defense Responses to Enhance Cell Survival at the Emergence of Oxidative Stress

Kah Poh Tan 1, Mingdong Yang 2, Shinya Ito 2*

1 The Hospital for Sick Children 2 Hospital for Sick Children

* Address correspondence to: E-mail: shinya.ito{at}sickkids.ca

Abstract

Oxidative stress, causing necrotic and apoptotic cell death, is associated with bile acid toxicity. Using liver (HepG2, Hepa1c1c7, and primary human hepatocytes) and intestinal (C2bbe1, a Caco-2 subclone) cells, we demonstrated that toxic bile acids, such as lithocholic acid (LCA) and chenodeoxycholic acid, induced the NF-E2-related factor 2 (Nrf2) target genes, especially glutamate-cysteine ligase subunits (GCLM and GCLC), the rate-limiting enzyme in glutathione (GSH) biosynthesis, and thioredoxin reductase 1. Nrf2 activation and induction of Nrf2 target genes were also evident in-vivo in the liver of CD-1 mice treated 7-8 h or 4 d with LCA. Silencing of Nrf2 via small-interfering RNA suppressed basal and bile acid-induced mRNA levels of the above genes. Consistent with this, overexpression of Nrf2 enhanced, but of dominant-negative Nrf2 attenuated, Nrf2 target gene induction by bile acids. The activation of Nrf2-ARE (antioxidant responsive element) transcription machinery by bile acids was confirmed by increased nuclear accumulation of Nrf2, enhanced ARE-reporter activity, and increased Nrf2 binding to ARE. Importantly, Nrf2 silencing increased cell susceptibility to LCA toxicity, as evidenced by reduced cell viability, and increased necrosis and apoptosis. Concomitant with GCLC/GCLM induction, cellular glutathione (GSH) was significantly increased in bile acid-treated cells. Cotreatment with N-acetyl-L-cysteine, a GSH precursor, ameliorated LCA toxicity, whereas cotreatment with buthionine sulfoximine, a GSH synthesis blocker, exacerbated it. In summary, this study provides molecular evidence linking bile acid toxicity to oxidative stress. Nrf2 is centrally involved in counteracting such oxidative stress by enhancing adaptive antioxidative response, particularly GSH biosynthesis, and hence cell survival.


Key words: Phase II enzymes, Quinone oxidoreductase, Regulation - transcriptional, Regulation - xenobiotic, Apoptosis, Glutathione, Mitochondrial toxins, Oxidative stress/antioxidants, Toxicant-induced gene express, Oxidative stress


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Okada, J. Shoda, K. Taguchi, J. M. Maher, K. Ishizaki, Y. Inoue, M. Ohtsuki, N. Goto, K. Takeda, H. Utsunomiya, et al.
Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice
Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G735 - G747.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics